These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Gougerot-Sjögren syndrome. Risk of lymphoma].
    Author: Mariette X.
    Journal: Presse Med; 1999 Jun 19; 28(22):1214-8. PubMed ID: 10414252.
    Abstract:
    LYMPHOMA RISK: Lymphoma is a very severe complication of primary Sjögren's syndrome: 5 to 10% of patients followed for more than 10 years will develop a lymphoma. Predictive factors include serum monoclonal immunoglobulins or cryoglobulins and a B clone population in accessory salivary glands. TYPICAL CLINICAL AND HISTOLOGICAL PRESENTATION: Mucosal involvement (parotid as well as gastric or pulmonary localizations) is frequent. According to the recent classification of lymphomas, most lymphomas developing in patients with Sjögren's syndrome are B lymphomas of the marginal zone: MALT lymphomas or low-grade nodal monocytoid lymphomas which are sometimes not identified until transformation to the giant cell stage. SIMILARITIES WITH HEPATITIS C LYMPHOMAS: The pathophysiology of lymphoma in Sjögrën's syndrome remains unknown. To date, there is no argument favoring a viral infection or a deregulation of a unique oncogene or anti-oncogene. Certain similarities between lymphomas in Sjögren's syndrome and lymphomas associated with hepatitic C virus would suggest a common pathogenisis: possibly a permanent stimulation of auto-reactive B cells carrying a surface immunoglobulin with rheumatoid factor activity in the target organs of the autoimmune disease. These B lymphocytes would then proliferate secondarily.
    [Abstract] [Full Text] [Related] [New Search]